Hitamo
Jdk afite ibikoresho byambere byitsinda ryakazi hamwe nibikoresho byo gucunga ubuziranenge, bizeza itangazo rihamye rya API hagati. Ikipe yabigize umwuga yizeza R & D ibicuruzwa. Kurwanya byombi, dushakisha CMO & CDMO mumasoko yo murugo kandi mpuzamahanga.
Ibisobanuro by'ibicuruzwa
Kubwingenzi, 17-amino-10-oxy-3,6,6,12,15,15-Tetraoxa-9-Ikinyamico ya AcideCanoic ifite ubushobozi bukomeye mubyiciro bitandukanye. Imiterere yayo ya molekelar hamwe nibidasanzwe byibintu bigira umutungo w'agaciro mugutezimbere ibiyobyabwenge, ibinyabuzima nibikorwa bya siyansi bifitanye isano.
Kimwe mubintu nyamukuru biranga iki gicuruzwa ni byinshi. 17-Amino-10-Oxy-3,6,6,12,15-Tetraoxa-9-Ikinyamakuru AzaptadeCanoic Acide ya molekile zitandukanye za bioative, nko kuringaniza na poptine. Amatsinda yacyo nicide aside aside aside ingana neza kandi asobanutse neza, akemeza urwego rwinshi rwo kugenzura kandi yihariye kubishushanyo mbonera.
Abashakashatsi n'abahanga mu mirimo y'ubuvuzi no kuvumbura ibiyobyabwenge bazakungukirwa cyane no kwinjiza iki gicuruzwa mubushakashatsi bwabo. Ibishoboka byose biva muri sisitemu yo gutanga ibiyobyabwenge bigamije iterambere ryabakozi ba transrapeutic. Mugutanga imitungo idasanzwe ya 17-10-oxy-10,6,12,15.15-Tetraoxa-9 - Amasosiyete ya farumacecanoic, ibigo bya farumasi birashobora guhanga udushya kandi bitera intangarugero ku ndwara zitandukanye.
Byongeye kandi, ibicuruzwa bikomeye bituma habaho umutekano no kwizerwa mubihe bitandukanye byubushakashatsi. Uburemere bwayo hamwe nogushiraho byateguwe neza kugirango utange ibibazo byiza, wemerera kwishyira hamwe muri protocole yubushakashatsi. Byongeye kandi, ubuziranenge bwibicuruzwa hamwe ningwate yo guhanara bivamo ibisubizo, bikabigira igikoresho cyingenzi kubisubizo byizewe.
Ku bijyanye n'umutekano, dufata ingamba zose kugira ngo tumenye ko 17-amino-10-oxy-3,6,12,15-TETRAOXA-ACID ACID yujuje ubuziranenge bwo mu rwego rwo hejuru. Ingamba zifatika zo kugenzura zifatwa muburyo bwo gukora kugirango habeho umwanda cyangwa umwanda.
